Professor Erwei Song - To be hot or not to be: That is the question of Cancer Immunotherapy

Abstract

Effector immune cell deployment (EICD), which includes the priming, circulation, trafficking, activity and fate of anti-tumor effector immune cells, is a panorama to fully reflect the generation, distribution and development of anti-tumor immunity. Tumor antigen-specific T cells are main component of effector immune cells in anti-tumor immune responses. However, their generation, distribution and the underlying regulation mechanisms remain largely unknown.

In this talk, Professor Erwei Song will introduce his recent work which highlights the role of cross-presentation in generation of antigen-specific cytotoxic T lymphocytes and exemplifies long-range deployment of anti-tumor adaptive immunity that prevent distant organ metastasis.

Speaker bio

Erwei Song, MD. PhD

Professor of Breast Surgery
Member of Chinese Academy of Sciences,
Director of Health Science Center
President of Sun Yat-sen Memorial Hospital,
Sun Yat-sen University
China

Erwei Song is Professor of Breast Surgery at Sun Yat-sen University (SYSU), Member of Chinese Academy of Sciences, CMB (China Medical Board) Distinguished Professor and Fellow of the Royal Society of Biology (UK). Currently, he serves as Director of Health Science Center and President of Sun Yat-sen Memorial Hospital, SYSU. Erwei obtained his M.D. and Ph.D. at Zhongshan Medical School, and was trained as a surgeon at Sun Yat-sen Memorial Hospital, SYSU. He received post-doctoral training at Harvard Medical School in 2002 and became an instructor at the CBR Institute of Biomedical Research at Harvard in 2004.

Learn more about Professor Erwei Song